Summary: by Robert S. Miller. Dr. Gabriel Hortobagyi discusses the 2011 update of the ASCO guideline on the use of bone-modifying agents in patients with metastatic breast cancer.
Summary: by Robert S. Miller. Dr. Gabriel Hortobagyi discusses the 2011 update of the ASCO guideline on the use of bone-modifying agents in patients with metastatic breast cancer.